Today

Agents

Chat

Arena

Discover

More

App

Cytokinetics CEO Robert I. Blum sells 7,500 common shares for $575,700 - CYTK News | Rallies

Cytokinetics CEO Robert I. Blum sells 7,500 common shares for $575,700

CYTK•2026-08-10

CEO exercises options and sells shares

Cytokinetics President and CEO Robert I. Blum exercised 7,500 stock options at $10.60 on Aug. 10, 2026.
Blum sold 7,500 shares at $76.76 the same day.
Directly held common shares fell to 377,820 following the transactions.

Related News

Onto Innovation to host analyst event at NYSE

ONTO•2026-08-10

Encompass Health Prices Private Offering Of Additional 5.875% Senior Notes Due 2034

EHC•2026-08-10

RBC, BMO agree to sell Moneris to Francisco Partners for about $2 billion cash

Sources

S

Cytokinetics CEO Robert I. Blum sells 7,500 common shares for $575,700

Sec

2026-08-10

First Advantage Corporation Registers 87.45 Million Shares For Resale By Selling Stockholder

FA•2026-08-10

Ladder Capital Corp Announces Sale Of Jacksonville Office Property

LADR•2026-08-10